These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 15929722)

  • 1. Function of the cysteine-rich domain of the haemorrhagic metalloproteinase atrolysin A: targeting adhesion proteins collagen I and von Willebrand factor.
    Serrano SM; Jia LG; Wang D; Shannon JD; Fox JW
    Biochem J; 2005 Oct; 391(Pt 1):69-76. PubMed ID: 15929722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of the cysteine-rich domain of snake venom metalloproteinases with the A1 domain of von Willebrand factor promotes site-specific proteolysis of von Willebrand factor and inhibition of von Willebrand factor-mediated platelet aggregation.
    Serrano SMT; Wang D; Shannon JD; Pinto AFM; Polanowska-Grabowska RK; Fox JW
    FEBS J; 2007 Jul; 274(14):3611-3621. PubMed ID: 17578514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mapping von Willebrand factor A domain binding sites on a snake venom metalloproteinase cysteine-rich domain.
    Pinto AF; Terra RM; Guimaraes JA; Fox JW
    Arch Biochem Biophys; 2007 Jan; 457(1):41-6. PubMed ID: 17118332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of platelet aggregation by the recombinant cysteine-rich domain of the hemorrhagic snake venom metalloproteinase, atrolysin A.
    Jia LG; Wang XM; Shannon JD; Bjarnason JB; Fox JW
    Arch Biochem Biophys; 2000 Jan; 373(1):281-6. PubMed ID: 10620350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adhesive domains in the collagen III fragment alpha1(III)CB4 that support alpha2beta1- and von Willebrand factor-mediated platelet adhesion under flow conditions.
    Verkleij MW; IJsseldijk MJ; Heijnen-Snyder GJ; Huizinga EG; Morton LF; Knight CG; Sixma JJ; de Groot PG; Barnes MJ
    Thromb Haemost; 1999 Sep; 82(3):1137-44. PubMed ID: 10494778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of sites in the cysteine-rich domain of the class P-III snake venom metalloproteinases responsible for inhibition of platelet function.
    Kamiguti AS; Gallagher P; Marcinkiewicz C; Theakston RD; Zuzel M; Fox JW
    FEBS Lett; 2003 Aug; 549(1-3):129-34. PubMed ID: 12914938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complete amino acid sequence of kaouthiagin, a novel cobra venom metalloproteinase with two disintegrin-like sequences.
    Ito M; Hamako J; Sakurai Y; Matsumoto M; Fujimura Y; Suzuki M; Hashimoto K; Titani K; Matsui T
    Biochemistry; 2001 Apr; 40(14):4503-11. PubMed ID: 11284707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different regions of the class P-III snake venom metalloproteinase jararhagin are involved in binding to alpha2beta1 integrin and collagen.
    Tanjoni I; Evangelista K; Della-Casa MS; Butera D; Magalhães GS; Baldo C; Clissa PB; Fernandes I; Eble J; Moura-da-Silva AM
    Toxicon; 2010 Jun; 55(6):1093-9. PubMed ID: 20056118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding of von Willebrand factor to collagen type III: role of specific amino acids in the collagen binding domain of vWF and effects of neighboring domains.
    van der Plas RM; Gomes L; Marquart JA; Vink T; Meijers JC; de Groot PG; Sixma JJ; Huizinga EG
    Thromb Haemost; 2000 Dec; 84(6):1005-11. PubMed ID: 11154106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cysteine-rich domain of snake venom metalloproteinases is a ligand for von Willebrand factor A domains: role in substrate targeting.
    Serrano SM; Kim J; Wang D; Dragulev B; Shannon JD; Mann HH; Veit G; Wagener R; Koch M; Fox JW
    J Biol Chem; 2006 Dec; 281(52):39746-56. PubMed ID: 17040908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. von Willebrand factor without the A2 domain is resistant to proteolysis.
    Lankhof H; Damas C; Schiphorst ME; Ijsseldijk MJ; Bracke M; Furlan M; Tsai HM; de Groot PG; Sixma JJ; Vink T
    Thromb Haemost; 1997 May; 77(5):1008-13. PubMed ID: 9184419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The hemorrhagin catrocollastatin inhibits collagen-induced platelet aggregation by binding to collagen via its disintegrin-like domain.
    Zhou Q; Dangelmaier C; Smith JB
    Biochem Biophys Res Commun; 1996 Feb; 219(3):720-6. PubMed ID: 8645248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A3 domain is essential for interaction of von Willebrand factor with collagen type III.
    Lankhof H; van Hoeij M; Schiphorst ME; Bracke M; Wu YP; Ijsseldijk MJ; Vink T; de Groot PG; Sixma JJ
    Thromb Haemost; 1996 Jun; 75(6):950-8. PubMed ID: 8822592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Function of disintegrin-like/cysteine-rich domains of atrolysin A. Inhibition of platelet aggregation by recombinant protein and peptide antagonists.
    Jia LG; Wang XM; Shannon JD; Bjarnason JB; Fox JW
    J Biol Chem; 1997 May; 272(20):13094-102. PubMed ID: 9148922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The disintegrin-like domain of the snake venom metalloprotease alternagin inhibits alpha2beta1 integrin-mediated cell adhesion.
    Souza DH; Iemma MR; Ferreira LL; Faria JP; Oliva ML; Zingali RB; Niewiarowski S; Selistre-de-Araujo HS
    Arch Biochem Biophys; 2000 Dec; 384(2):341-50. PubMed ID: 11368322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purification and characterization of kaouthiagin, a von Willebrand factor-binding and -cleaving metalloproteinase from Naha kaouthia cobra venom.
    Hamako J; Matsui T; Nishida S; Nomura S; Fujimura Y; Ito M; Ozeki Y; Titani K
    Thromb Haemost; 1998 Sep; 80(3):499-505. PubMed ID: 9759634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Jararhagin and its multiple effects on hemostasis.
    Laing GD; Moura-da-Silva AM
    Toxicon; 2005 Jun; 45(8):987-96. PubMed ID: 15922770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The collagen-binding leech products rLAPP and calin prevent both von Willebrand factor and alpha2beta1(GPIa/IIa)-I-domain binding to collagen in a different manner.
    Depraetere H; Kerekes A; Deckmyn H
    Thromb Haemost; 1999 Sep; 82(3):1160-3. PubMed ID: 10494781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of peptide antagonists to glycoprotein Ibalpha that selectively inhibit von Willebrand factor dependent platelet aggregation.
    Benard SA; Smith TM; Cunningham K; Jacob J; DeSilva T; Lin L; Shaw GD; Kriz R; Kelleher KS
    Biochemistry; 2008 Apr; 47(16):4674-82. PubMed ID: 18363340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aurin tricarboxylic acid inhibits platelet adhesion to collagen by binding to the 509-695 disulphide loop of von Willebrand factor and competing with glycoprotein Ib.
    Girma JP; Fressinaud E; Christophe O; Rouault C; Obert B; Takahashi Y; Meyer D
    Thromb Haemost; 1992 Dec; 68(6):707-13. PubMed ID: 1287886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.